1. 151P Clinical outcome and preliminary immune analysis of phase II clinical trial of combination of tocilizumab with ipilimumab and nivolumab for patients with treatment naïve metastatic melanoma. (December 2022) Authors: Montazari, E.J.J.; Abdel-Wahab, N.; Johnson, D.; Spillson, C.; Elsayes, K.M.; Duan, F.; Yadav, S.; Allison, J.; Sharma, P.; Diab, A. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗